בייאטה 5 מק"ג ישראל - עברית - Ministry of Health

בייאטה 5 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

בייאטה 5 מק"ג ישראל - עברית - Ministry of Health

בייאטה 5 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

בייאטה 10 מק"ג ישראל - עברית - Ministry of Health

בייאטה 10 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

בייאטה 10 מק"ג ישראל - עברית - Ministry of Health

בייאטה 10 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

פרוסטין F2 אלפא ישראל - עברית - Ministry of Health

פרוסטין f2 אלפא

pfizer pharmaceuticals israel ltd - dinoprost trometamol 5 mg / 1 ml - solution for injection - dinoprost - therapeutic termination of pregnancy second trimester by intra-amniotic administration.

T61 וטרינרי ישראל - עברית - Ministry of Health

t61 וטרינרי

intervet ( israel) ltd - embutramide 200 mg/ml; mebezonium 50 mg/ml - solution for injection - for euthanasia of dogs, cats and other animals.

אופטלגין זריקות ישראל - עברית - Ministry of Health

אופטלגין זריקות

teva pharmaceutical indust.ltd - dipyrone 1 g / 2 ml - solution for injection - metamizole sodium - as an analgesic: optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. intramuscular administration of dipyrone for relief of pain is not recommended.however, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. as an antipyretic: optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.

מתוטרקסאט "אבווה" 10 מ"ג/מ"ל ישראל - עברית - Ministry of Health

מתוטרקסאט "אבווה" 10 מ"ג/מ"ל

pharmalogic ltd - methotrexate 10 mg/ml - solution for injection - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. methotrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, methotrexate is indicated only in the

רמוואב ישראל - עברית - Ministry of Health

רמוואב

neopharm scientific ltd - catumaxomab 100 mcg/ml - concentrate for solution for infusion - catumaxomab - intraperitoneal treatment of malignant ascites in patients with epcam-positive carcinomas where standard therapy is not available or no longer feasible.

סאפנלו ישראל - עברית - Ministry of Health

סאפנלו

astrazeneca (israel) ltd - anifrolumab - תרכיז להכנת תמיסה לאינפוזיה - anifrolumab 150 mg/ml - anifrolumab